PointState Capital’s Merck MRK Stock Holding History

PointState Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,826	Closed	-$5.09M	–	66
2022 Q2	$5.09M	Buy	+55,826	New	+$4.95M	0.13%	44
2022 Q1	–	Sell	-70,000	Closed	-$5.37M	–	109
2021 Q4	$5.37M	Sell	70,000 -495,925	-88%	-$39.5M	0.09%	83
2021 Q3	$42.5M	Buy	565,925 +445,925	+372%	+$33.9M	0.71%	42
2021 Q2	$9.33M	Buy	120,000 +83,320	+227%	+$6.2M	0.16%	79
2021 Q1	$2.7M	Sell	36,680 -198,415	-84%	-$14.6M	0.05%	107
2020 Q4	$18.4M	Sell	235,095 -329,349	-58%	-$25.2M	0.34%	60
2020 Q3	$44.7M	Buy	+564,444	New	+$44.2M	1.17%	25
2019 Q2	–	Sell	-1,076,401	Closed	-$85.4M	–	140
2019 Q1	$85.4M	Buy	+1,076,401	New	+$80.5M	1.69%	20
2018 Q4	–	Sell	-125,760	Closed	-$8.51M	–	119
2018 Q3	$8.51M	Buy	+125,760	New	+$8.01M	0.11%	81
2018 Q2	–	Sell	-967,933	Closed	-$50.3M	–	190
2018 Q1	$50.3M	Buy	+967,933	New	+$52.3M	0.55%	52
2016 Q4	–	Sell	-2,899,711	Closed	-$173M	–	149
2016 Q3	$173M	Buy	+2,899,711	New	+$170M	1.78%	10

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PointState Capital's MRK Position: Q3 2022 in Review

PointState Capital sold out of Merck (MRK) in Q3 2022, closing a stake of 55,826 shares — an estimated $5.09M sold.

PointState Capital first reported a position in MRK in Q3 2016 and held it in 11 quarters. The position peaked at $173M in Q3 2016. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

PointState Capital reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
PointState Capital sold 55,826 Merck shares in Q3 2022, an estimated $5.09M.
PointState Capital first reported a position in Merck in Q3 2016 and held it in 11 quarters.
PointState Capital's Merck position peaked at $173M in Q3 2016.
2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on PointState Capital's 13F filing for Q3 2022, filed 10 Nov 2022.